Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix)

This publication has 17 references indexed in Scilit:

• Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist
  Fertility and Sterility, 1993
• Applications of Gonadotropin-Releasing Hormone Analogues in the Treatment of Premenstrual Syndrome
  Clinical Obstetrics and Gynecology, 1993
• Gonadotropin-Releasing Hormone Antagonist plus Testosterone: A Potential Male Contraceptive*
  Journal of Clinical Endocrinology & Metabolism, 1991
• Effectiveness of the gonadotropin-releasing hormone agonist buserelin in the treatment of children with true and complete, central isosexual precocity
  Adolescent and Pediatric Gynecology, 1991
• Differential Regulation of Luteinizing Hormone, Follicle-Stimulating Hormone, and Free α-Subunit Secretion from the Gonadotrope by Gonadotropin-Releasing Hormone (GnRH): Evidence from the Use of Two GnRH Antagonists*
  Journal of Clinical Endocrinology & Metabolism, 1990
• Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imaging
  American Journal of Obstetrics and Gynecology, 1988
• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
  New England Journal of Medicine, 1988
• Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
  Journal of Clinical Endocrinology & Metabolism, 1986
• Ovulation Inhibition by Administration of Weekly Gonadotropin-Releasing Hormone Antagonist
  Journal of Clinical Endocrinology & Metabolism, 1986
• The Molecular Basis of Gonadotropin-Releasing Hormone Action*
  Endocrine Reviews, 1986